Modern management of rheumatoid arthritis—making a case for early aggressive medical treatment

References

• Burton W, Morrison A, Maclean R, Ruderman E: Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 2006, 56(1): 18–27.
   PubMed Web of Science ®Google Scholar
• Naz SM, Symmons DP: Mortality in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007, 21(5): 871–883.
   PubMed Web of Science ®Google Scholar
• Strand V, Singh JA: Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care 2008, 14(4): 234–254.
   PubMed Web of Science ®Google Scholar
• Welsing PM, Landewe RB, van Riel PL, Boers M, van Gestel AM, van der Linden S, Swinkels HL, van der Heijde DM: The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 2004, 50(7): 2082–2093.
   PubMed Web of Science ®Google Scholar
• Bakker MF, Jacobs JW, Verstappen SM, Bijlsma JW: Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility. Ann Rheum Dis 2007, 66 Suppl 3: iii56–60.
   PubMedGoogle Scholar
• Gorman JD, Criswell LA: The shared epitope and severity of rheumatoid arthritis. Rheum Dis Clin North Am 2002, 28(1): 59–78.
   PubMed Web of Science ®Google Scholar
• Vittecoq O, Lequerre T, Goeb V, Le Loet X, Abdesselam TA, Klemmer N: Smoking and inflammatory diseases. Best practice & research 2008, 22(5): 923–935.
   PubMed Web of Science ®Google Scholar
• Machold KP, Nell V, Stamm T, Aletaha D, Smolen JS: Early rheumatoid arthritis. Current opinion in rheumatology 2006, 18(3): 282–288.
   PubMed Web of Science ®Google Scholar
• Muller-Ladner U, Pap T, Gay RE, Neidhart M, Gay S: Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol 2005, 1(2): 102–110.
   PubMedGoogle Scholar
• Mikuls TR, Hughes LB, Westfall AO, Holers VM, Parrish L, van der Heijde D, van Everdingen M, Alarcon GS, Conn DL, Jonas B et al: Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis 2008, 67(11): 1529–1534.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31(3): 315–324.
   PubMed Web of Science ®Google Scholar
• Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS: Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002, 61(4): 290–297.
   PubMed Web of Science ®Google Scholar
• van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ: Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002, 4(2): 87–93.
   PubMedGoogle Scholar
• Niewold TB, Harrison MJ, Paget SA: Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis. QJM 2007, 100(4): 193–201.
   PubMed Web of Science ®Google Scholar
• Boonen A, van der Heijde D: Conventional x-ray in early arthritis. Rheum Dis Clin North Am 2005, 31(4): 681–698.
   PubMed Web of Science ®Google Scholar
• American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines: Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 2002, 46: 328–346.
   PubMed Web of Science ®Google Scholar
• Pham K, Hirschberg R: Global safety of coxibs and NSAIDs. Curr Top Med Chem 2005, 5(5): 465–473.
   PubMed Web of Science ®Google Scholar
• Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Sieper J, Emery P, Keystone EC, Schiff MH, Mease P et al: Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007. Ann Rheum Dis 2007, 66 Suppl 3: iii2–22.
   Google Scholar
• Dougados M, Aletaha D, van Riel P: Disease activity measures for rheumatoid arthritis. Clin Exp Rheumatol 2007, 25(5 Suppl 46): S22–29.
   Google Scholar
• Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, Kincaid W, Porter D: Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004, 364(9430): 263–269.
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F: The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1991, 35: 498–502.
   Web of Science ®Google Scholar
• Morel J, Combe B: How to predict prognosis in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2005, 19(1): 137–146.
   PubMed Web of Science ®Google Scholar
• Kalla AA, Stanwix A, Gotlieb D, Asherson RA, Mody GM: Rheumatoid arthritis: clinical guideline 2003. S Afr Med J 2003, 93(12 Pt 2): 991–1012.
   PubMedGoogle Scholar
• Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I, Belmonte MA, Tena X, Sanmarti R: Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 2003, 30(7): 1436–1439.
   PubMed Web of Science ®Google Scholar